Regenerating Islet Derived Protein 1 Alpha (REG1A) Antibody (FITC)

Product Graph
169€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Regenerating Islet Derived Protein 1 Alpha (REG1A) Antibody (FITC)
category
Primary Antibodies
provider
Abbexa
reference
abx305097

Description

REG1A Antibody (FITC) is a Rabbit Polyclonal against REG1A conjugated to FITC.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Regenerating Islet Derived Protein 1 Alpha (REG1A)
Host
Rabbit
Reactivity
Human
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
FITC
Isotype
IgG
Purity
> 95%
Purification
Purified by Protein G.
Size 1
20 µg
Size 2
50 µg
Size 3
100 µg
Size 4
200 µg
Size 5
1 mg
Form
Liquid
Buffer
0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid exposure to light. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P05451
Gene ID
5967
OMIM
167770
Background
Antibody anti-REG1A
Status
RUO

Descripción

Related Products

Pr22412

Recombinant Human REG1A

Ver Producto
abx006293

Regenerating Islet Derived Protein 1 Alpha (REG1A) Antibody

REG1A Antibody is a Rabbit Polyclonal Antibody against REG1A.

Ver Producto
abx011453

Regenerating Islet Derived Protein 1 Alpha (REG1A) Antibody

REG1A (regenerating islet-derived 1 alpha), also known as PTP, PSP, is a member of the Reg family of secreted proteins with a C-type lectin domain. REG1A is associated with islet cell regeneration and diabetogenesis and may be involved in pancreatic lithogenesis.Due to variable glycosylation, pancreatic REG1A exists as multiple species of 16 - 18 kDa. REG1A promotes the maintenance and growth of pancreatic islet beta cells and intestinal villi. It is upregulated in pancreatitis and some carcinomas. REG1A is an antigenic target in autoimmune diabetes.

Ver Producto